Agilent Technologies Secures Patent for CGH Assays
21-08-2012: Agilent Technologies Inc. announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in both basic and clinical research.
The U.S. patent (No. 8,232,055) has claims for measuring copy number changes in genomic DNA, covering both one-color and two-color assays using oligonucleotide probes and samples with high-sequence complexity, such as human genomic DNA samples.
Agilent’s copy number method, commercially introduced in 2005, uses long oligonucleotide probes, enabling high specificity and sensitivity. For example, samples containing as low as 8 percent abnormal cells may be confidently analyzed with Agilent’s copy number method.
The method was originally developed to improve upon older copy number assays that use long genomic fragments such as bacterial artificial chromosomes. (BACs often contain repetitive regions.) The method also improves upon other oligonucleotide array assays, which depend on sample preparation methods that remove significant portions of the genomic DNA content. Agilent’s higher-resolution platform allows users to detect much smaller genomic aberrations throughout complex genomes.
- 1The shadow of a disease
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3Food analysis and diagnostics are hot topics at analytica China 2014
- 4Faster, cheaper tests for sickle cell
- 5SCHOTT Is Now a Stock Corporation
- 6Analytik Jena Closes Acquisition of Bruker's ICP-MS Business and Begins Integration Process
- 7LGC rebrands reference standards
- 8Perten Instruments acquires Newport Scientific
- 9Perten Instruments and Newport Scientific announce distribution agreement for the Nordic countries
- 10Spectris acquires Corporate Scientific Claisse Inc.
- Graphene imperfections key to creating hypersensitive 'electronic nose'
- Large study reveals new genetic variants that raise risk for prostate cancer
- Advanced light source sets microscopy record
- Faster, cheaper tests for sickle cell
- Genomic sequencing reveals mutations, insights into 2014 Ebola outbreak